JAZZ  valuation analysis

Name: Jazz Pharmaceuticals plc
Description: Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Nov 02, 2020
Market cap: $9.28B (455th)
Sales(TTM): $2.28B (655th)
Earnings(TTM): $179.19M (552nd)

FFER: 0.89*
Actual price: $165.75
* Earnings were reported Feb 23, 2021 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2021-03-02
Price & Estimates
Sales & Earnings history (TTM)
No notables found through heuristics.
Earnings / MarketCap
Jazz Pharmaceuticals plc
"Biotechnology" industry
Sales / MarketCap
Jazz Pharmaceuticals plc
"Biotechnology" industry
Book / MarketCap
Jazz Pharmaceuticals plc
"Biotechnology" industry
Equity / Assets
Jazz Pharmaceuticals plc
"Biotechnology" industry